256 related articles for article (PubMed ID: 24630947)
1. Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group.
Leoni S; Piscaglia F; Serio I; Terzi E; Pettinari I; Croci L; Marinelli S; Benevento F; Golfieri R; Bolondi L
Dig Liver Dis; 2014 Jun; 46(6):549-55. PubMed ID: 24630947
[TBL] [Abstract][Full Text] [Related]
2. Real Life Treatment of Hepatocellular Carcinoma: Impact of Deviation from Guidelines for Recommended Therapy.
Alkhatib A; Gomaa A; Allam N; Rewisha E; Waked I
Asian Pac J Cancer Prev; 2015; 16(16):6929-34. PubMed ID: 26514470
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatocellular carcinoma in Child-Pugh B patients.
Piscaglia F; Terzi E; Cucchetti A; Trimarchi C; Granito A; Leoni S; Marinelli S; Pini P; Bolondi L
Dig Liver Dis; 2013 Oct; 45(10):852-8. PubMed ID: 23582346
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
Yamakado K; Kudo M
Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
[TBL] [Abstract][Full Text] [Related]
5. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Han JE; Cho HJ; Cheong JY; Lim SG; Yang MJ; Noh CK; Lee GH; Kim SS
World J Gastroenterol; 2023 Dec; 29(47):6122-6137. PubMed ID: 38186683
[TBL] [Abstract][Full Text] [Related]
6. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.
Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R;
Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477
[TBL] [Abstract][Full Text] [Related]
7. Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Guarino M; Tortora R; de Stefano G; Coppola C; Morisco F; Salomone Megna A; Izzo F; Nardone G; Piai G; Adinolfi LE; D'Adamo G; Gaeta GB; Messina V; Francica G; De Girolamo V; Coppola N; Persico M; Di Costanzo GG;
J Gastroenterol Hepatol; 2018 May; 33(5):1123-1130. PubMed ID: 28994145
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J
Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Approach in Hepatocellular Carcinoma in a Level II Hospital: The First Decade of Hospital Universitario Fundacion Alcorcon.
Loinaz Segurola C; LIedó Navarro JL; Burgos Rde L; Martín Ríos D; Ochando Cerdán F; Alonso López S; Martel Villagrán J; Gutiérrez Garcia ML; Fernandez Cebrián JM; Fernández Rodríguez C
Hepatogastroenterology; 2015 Jun; 62(140):971-7. PubMed ID: 26902039
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation.
Perry JF; Charlton B; Koorey DJ; Waugh RC; Gallagher PJ; Crawford MD; Verran DJ; McCaughan GW; Strasser SI
Liver Int; 2007 Nov; 27(9):1240-8. PubMed ID: 17919236
[TBL] [Abstract][Full Text] [Related]
11. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
[TBL] [Abstract][Full Text] [Related]
12. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
[TBL] [Abstract][Full Text] [Related]
14. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C.
Wang JH; Kuo YH; Wang CC; Chen CL; Cheng YF; Hsu HC; Lu SN
Dig Liver Dis; 2013 Jun; 45(6):510-5. PubMed ID: 23218990
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
18. Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: a real-life retrospective analysis in a Hong Kong regional hospital.
Yip WM; Hung HG; Lok KH; Li KF; Li KK; Szeto ML
Hong Kong Med J; 2009 Oct; 15(5):339-45. PubMed ID: 19801690
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of same-day discharge of patients with hepatocellular carcinoma treated with transarterial chemoembolization with drug-eluting beads in a liver transplantation program.
Nasser F; Cavalcante RN; Galastri FL; de Rezende MB; Felga GG; Travassos FB; De Fina B; Affonso BB
J Vasc Interv Radiol; 2014 Jul; 25(7):1012-7. PubMed ID: 24704346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]